Sansure Biotech Inc. (688289.SS)
CNY 19.81
(-0.4%)
CNY 19.81
(-0.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.45 Billion CNY | -7.84% |
| 2022 | 9.17 Billion CNY | 29.38% |
| 2021 | 7.09 Billion CNY | 29.99% |
| 2020 | 5.45 Billion CNY | 748.98% |
| 2019 | 642.46 Million CNY | 16.38% |
| 2018 | 552.04 Million CNY | -2.4% |
| 2017 | 565.61 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 8.57 Billion CNY | -0.71% |
| 2024 Q1 | 8.74 Billion CNY | 3.45% |
| 2024 Q2 | 8.63 Billion CNY | -1.3% |
| 2023 Q4 | 8.45 Billion CNY | 1.76% |
| 2023 FY | 8.45 Billion CNY | -7.84% |
| 2023 Q3 | 8.3 Billion CNY | 0.79% |
| 2023 Q1 | 8.72 Billion CNY | -4.87% |
| 2023 Q2 | 8.24 Billion CNY | -5.55% |
| 2022 Q3 | 8.59 Billion CNY | 5.56% |
| 2022 Q2 | 8.14 Billion CNY | 4.27% |
| 2022 Q1 | 7.81 Billion CNY | 10.17% |
| 2022 FY | 9.17 Billion CNY | 29.38% |
| 2022 Q4 | 9.17 Billion CNY | 6.7% |
| 2021 Q4 | 7.09 Billion CNY | 0.3% |
| 2021 Q2 | 6.35 Billion CNY | 2.05% |
| 2021 Q1 | 6.23 Billion CNY | 14.24% |
| 2021 Q3 | 7.06 Billion CNY | 11.17% |
| 2021 FY | 7.09 Billion CNY | 29.99% |
| 2020 Q3 | 5.15 Billion CNY | 106.34% |
| 2020 Q4 | 5.45 Billion CNY | 5.75% |
| 2020 Q2 | 2.49 Billion CNY | 142.87% |
| 2020 Q1 | 1.02 Billion CNY | 60.2% |
| 2020 FY | 5.45 Billion CNY | 748.98% |
| 2019 Q4 | 642.46 Million CNY | 0.0% |
| 2019 FY | 642.46 Million CNY | 16.38% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 552.04 Million CNY | -2.4% |
| 2017 FY | 565.61 Million CNY | 0.0% |